Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Upstream Bio Inc (UPB)

Upstream Bio Inc (UPB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 868,807
  • Shares Outstanding, K 53,597
  • Annual Sales, $ 2,380 K
  • Annual Income, $ -20,537 K
  • EBIT $ 0 M
  • EBITDA $ 0 M
  • 60-Month Beta N/A
  • Price/Sales 377.10
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings $-6.96 on 11/07/24
  • Next Earnings Date 02/06/25
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.56
  • Number of Estimates 4
  • High Estimate -0.39
  • Low Estimate -0.77
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.97 +8.28%
on 12/19/24
24.98 -35.10%
on 12/09/24
-1.80 (-9.99%)
since 11/20/24

Most Recent Stories

More News
Should You Scoop Up This 'Strong Buy' Biotech Before December 23?

Does this top-rated biotech stock deserve a spot in investors' portfolios before its Russell 2000 inclusion?

UPB : 16.21 (-2.41%)
REGN : 701.85 (-0.90%)
AMGN : 263.38 (+0.84%)
Upstream Bio Appoints Allison Ambrose as General Counsel

UPB : 16.21 (-2.41%)
Upstream Bio, Inc. to Join Russell 2000® Index Effective December 23, 2024

Upstream Bio will join the Russell 2000® index on December 23, 2024, amid its clinical development of inflammatory disease treatments.Quiver AI SummaryUpstream Bio, Inc., a clinical-stage biotechnology...

UPB : 16.21 (-2.41%)
Upstream Bio Announces Addition to Russell 2000® Index

UPB : 16.21 (-2.41%)
Upstream Bio to Participate in the Piper Sandler 36th Annual Healthcare Conference

UPB : 16.21 (-2.41%)
Upstream Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights

UPB : 16.21 (-2.41%)
Discover the 3 Best-Performing Biotech IPO Stocks of 2024

Check out which three biotechnology companies that went public in 2024 and are performing the best and a big factor influenced their rise.

UPB : 16.21 (-2.41%)
JNJ : 144.47 (+0.62%)
CGON : 28.67 (+2.32%)
AVBP : 26.09 (+1.72%)
Upstream Bio Announces Closing of $293 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

UPB : 16.21 (-2.41%)
Upstream Bio Announces Pricing of Upsized Initial Public Offering

UPB : 16.21 (-2.41%)

Business Summary

Upstream Bio Inc. is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. The Company is developing verekitug, the only known antagonist currently in development which targets the receptor for thymic stromal lymphopoietin,...

See More

Key Turning Points

3rd Resistance Point 18.55
2nd Resistance Point 17.80
1st Resistance Point 17.01
Last Price 16.21
1st Support Level 15.46
2nd Support Level 14.71
3rd Support Level 13.92

See More

52-Week High 29.46
Fibonacci 61.8% 23.92
Fibonacci 50% 22.21
Fibonacci 38.2% 20.51
Last Price 16.21
52-Week Low 14.97

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar